Alexandra Perez

Dr. Alexandra Perez

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2014 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
DTDaniel R. Touchette
Daniel R. Touchette
FDFred Doloresco
Fred Doloresco
KSKatie J. Suda
Katie J. Suda
APAlexandra Perez
Alexandra Perez
STStuart Turner
Stuart Turner
JHJames M. Hoffman
James M. Hoffman

6 January 2009 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
APAlexandra Perez
Alexandra Perez
FDFred Doloresco
Fred Doloresco
JHJames M. Hoffman
James M. Hoffman
PMPatrick D. Meek
Patrick D. Meek
DTDaniel R. Touchette
Daniel R. Touchette
GSGlen T. Schumock
Glen T. Schumock


1 August 2009 in Clinical Therapeutics
Verified
Journal Article
Closed access
DSDevada Singh-Franco
Devada Singh-Franco
HGHoytin Lee Ghin
Hoytin Lee Ghin
GRGisela I. Robles
Gisela I. Robles
NBNancy Borja-Hart
Nancy Borja-Hart
APAlexandra Perez
Alexandra Perez

1 February 2017 in American Journal of Pharmaceutical Education
Verified
Journal Article
Closed access
PDF file
APAlexandra Perez
Alexandra Perez
SRSilvia Rabionet
Silvia Rabionet
BBBarry Bleidt
Barry Bleidt
Objectives. To implement and assess the effectiveness of a 15-week applied research elective that introduced students to secondary database analysis in clinical pharmacy. Design. In small groups, students learned, planned, developed and completed a secondary database study to answer an original research question. During one semester, they completed a basic research proposal and Institutional Review Board application, created and analyzed a National Health and Nutrition Examination Survey (NHANES) sample dataset, and reported the results in an abstract and poster presentation. Assessment. All deliverables resulted in high grades. Mean scores on a survey conducted following completion of the course revealed that students strongly agreed or agreed that they had high levels of confidence about performing research-related tasks. Eight student groups delivered poster presentations at professional conferences. Conclusions. Within one semester, student pharmacists with no or little research experience completed original research projects that contributed to pharmacy practice knowledge. They felt highly confident doing research-related tasks, and successfully disseminated their studies beyond the classroom.

10 December 2019 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
PDF file
BTBrian Talon
Brian Talon
APAlexandra Perez
Alexandra Perez
CYConnie Yan
Connie Yan
AAAli Alobaidi
Ali Alobaidi
KZKatherine H. Zhang
Katherine H. Zhang
DTDaniel R. Touchette
Daniel R. Touchette
Studies evaluating the cost‐effectiveness of clinical pharmacy services (CPS) are needed to justify implementation and reimbursement. Through a systematic review, we describe services provided by pharmacists and their economic outcomes. We conducted a literature search of published studies in PubMed, Ovid, and Embase from January 2011 through December 2017. Manuscripts evaluating a CPS with patient‐level economic outcomes and conducted in the United States were included. Study risks of bias were classified by study design characteristics. Economic evaluations were classified according to the presence of a comparator, and cost and outcome measures included. The quality of full economic evaluations was assessed using the Quality of Health Economic Studies (QHES) instrument. Descriptive statistics were used to summarize CPS characteristics. After screening, 115 studies were included. Type of service provided included general pharmacotherapy (41%), disease management (30%), and targeted drug program (17%). Settings included hospital (34%), ambulatory care (28%), and community pharmacy (17%). Study designs were considered high risk of bias (use of a historical control group or no control group) in 69% of cases while 25% were medium risk of bias (non‐randomized with a concurrent control group) and 6% were low risk of bias (randomized experimental or multigroup interrupted time series). Economic evaluation types were descriptive studies that measured cost and/or outcomes of a CPS (55%), comparative studies that measured cost or outcomes of a CPS and a comparator (37%), and full evaluations that measured cost and outcomes of a CPS and a comparator (8%). Among nine full evaluations, the median (range) QHES score was 74 (59‐95) and four reported the CPS as being more effective at a lower cost. Few full economic evaluations were conducted, but supported the cost‐effectiveness of CPS. Use of a comparator group and measurement of economic inputs and outcomes would strengthen the body of evidence.